Dr Philip Haycock attended the International Lung Cancer Consortium (ILCCO)
Dr Philip Haycock gives a summary of the International Lung Cancer Consortium (ILCCO) meeting in Los Angeles (24th-25th October 2022)
Dr Philip Haycock gives a summary of the International Lung Cancer Consortium (ILCCO) meeting in Los Angeles (24th-25th October 2022)
Boosting physical activity levels and curbing sitting time are highly likely to lower breast cancer risk, finds research designed to strengthen proof of causation. The study led by Cancer Council Victoria in Australia, and including the Bristol Medical School: Population Health Sciences, is published online today [6 September] in the British Journal of Sports Medicine.
The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics. The finding, made in one of the largest studies of its kind through genetic data analysis on 421,738 people, could pave the way for potential new approaches for the prevention and early detection of cancers including leukaemia.
The Bristol Network, which includes North Bristol NHS Trust (NBT), University Hospitals Bristol and Weston NHS Foundation Trust, Gloucestershire Hospitals NHS Foundation Trust, Royal United Hospitals Bath NHS Foundation Trust, has been recognised as a “Tessa Jowell Centre of Excellence” following rigorous expert-led assessments by the Tessa Jowell Brain Cancer Mission (TJBCM).
New research shows that lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study led by the University of Bristol and published today [19 April] in BMC Medicine.